Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02187744
Title A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
Recruitment Completed
Gender
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult
Covered Countries USA | SVK | POL | ITA | HUN | CZE


No variant requirements are available.